Jane Street’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Jane Street's CRL Position: Q3 2026 in Review
Jane Street increased its Charles River Laboratories (CRL) stake by 1,055% in Q3 2026, buying an estimated $11.8M and bringing the position to 49,094 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2395.
Jane Street first reported a position in CRL in Q2 2013 and has held it in 41 quarters since. The position peaked at $20.7M in Q1 2025. 591 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Jane Street held 49,094 shares of Charles River Laboratories worth $14.5M as of Q3 2026.
- Jane Street bought 44,843 Charles River Laboratories shares in Q3 2026, an estimated $11.8M.
- Charles River Laboratories made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #2395 holding.
- Jane Street first reported a position in Charles River Laboratories in Q2 2013 and has held it in 41 quarters since.
- Jane Street's Charles River Laboratories position peaked at $20.7M in Q1 2025.
- 591 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.